For the fiscal year, Alembic Pharmaceuticals declared an increased final dividend of ₹12.00 per equity share, representing a positive upward adjustment compared to the previous year's payout. The corporate board announced this distribution alongside strong quarterly financial disclosures, setting the official record and ex-dividend dates in late July to determine shareholder eligibility. This consistent cash return highlights management's dedication to rewarding long-term investors from operating cash flows while continuing to fund ongoing capital expenditures and global market expansion initiatives.